4.5 Article

Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 399, Issue C, Pages 178-189

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2014.08.014

Keywords

Diabetic nephropathy; Advanced glycation-end products; Oxidative stress; Sirt1; Polydatin; Nrf2-ARE pathway

Funding

  1. National Natural Science Foundation of China [81170676, 81373457]
  2. Major Science and Technology Project of China [2014ZX09301307008]
  3. Natural Science Foundation of Guangdong Province [S2012020010991, S2013010015765]
  4. Guangdong Major Science and Technology Project [2011A080502004, 20128050300017]
  5. Guangzhou Science and Technology Project [201300000061]
  6. Innovative Talents Training Programs of Ph.D. of Sun Yat-sen University [[2013]202]

Ask authors/readers for more resources

Sirt1 and nuclear factor-E2 related factor 2 (Nrf2)-anti-oxidant response element (ARE) anti-oxidative pathway play important regulatory roles in the pathological progression of diabetic nephropathy (DN) induced by advanced glycation-end products (AGEs). Polydatin (PD), a glucoside of resveratrol, has been shown to possess strong anti-oxidative bioactivity. Our previous study demonstrated that PD markedly resists the progression of diabetic renal fibrosis and thus, inhibits the development of DN. Whereas, whether PD could resist DN through regulating Sirt1 and consequently promoting Nrf2-ARE pathway needs further investigation. Here, we found that concomitant with decreasing RAGE (the specific receptor for AGEs) expression, PD significantly reversed the downregulation of Sirtl in terms of protein expression and deacetylase activity and attenuated FN and TGF-beta 1 expression in GMCs exposed to AGEs. Under AGEs-treatment condition, PD could decrease Keap1 expression and promote the nuclear content, ARE-binding ability, and transcriptional activity of Nrf2. In addition, PD increased the protein levels of heme oxygenase 1 (HO-1) and superoxide dismutase 1 (SOD 1), two target genes of Nrf2. The activation of Nrf2-ARE pathway by PD eventually led to the quenching of ROS overproduction sharply boosted by AGEs. Depletion of Sirtl blocked Nrf2-ARE pathway activation and reversed FN and TGF-beta 1 downregulation induced by PD in GMCs challenged with AGEs. Along with reducing HO-1 and SOD1 expression, silencing of Nrf2 increased FN and TGF-beta 1 levels. PD treatment elevated Sirt1 and Nrf2 levels in the kidney tissues of diabetic rats, then improved the anti-oxidative capacity and renal dysfunction of diabetic models, and finally reversed the upregulation of FN and TGF-beta 1. Taken together, the resistance of PD on upregulated FN and TGF-beta 1 induced by AGEs via oxidative stress in GMCs is closely associated with its activation of Sirt1-Nrf2-ARE pathway. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available